Page 4 - Eli Mintz News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Compugen Ltd. (NASDAQ:CGEN – Get Rating) – Equities research analysts at Oppenheimer issued their FY2026 earnings per share estimates for Compugen in a report released on Friday, February 25th. Oppenheimer analyst M. Breidenbach expects that the biotechnology company will post earnings of ($0.65) per share for the year. Oppenheimer has a “Outperform” rating and a […]

Compugen (NASDAQ:CGEN – Get Rating) had its target price decreased by Oppenheimer from $17.00 to $14.00 in a research note published on Friday, Analyst Price Targets reports. Oppenheimer currently has an outperform rating on the biotechnology company’s stock. Oppenheimer also issued estimates for Compugen’s FY2026 earnings at ($0.65) EPS. A number of other brokerages have […]